Treatment of Myositis Associated With Immune Checkpoint Inhibitors

Author:

Matas-García Ana,Martinez-Hernandez Eugenia,Milisenda José CésarORCID

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology

Reference30 articles.

1. •• Reynolds KL, Guidon AC. Diagnosis and management of immune checkpoint inhibitor-associated neurologic toxicity: illustrative case and review of the literature. Oncologist. 2019;24(4):435–443. Comprehensive recommendations for specific organ system–based toxicity diagnosis and management.

2. •• Jordan B, Benesova K, Hassel JC, Wick W, Jordan K. How we identify and treat neuromuscular toxicity induced by immune checkpoint inhibitors. ESMO Open. 2021;6(6):100317. A practical review of the therapeutic management algorithm according to severity of neuromuscular irAE following ESMO guidelines.

3. •• Matas-Garcia A, Milisenda JC, Selva-O’Callaghan A, et al. Emerging PD-1 and PD-1L inhibitors-associated myopathy with a characteristic histopathological pattern. Autoimmun Rev. 2020;19:102455. A characteristic clinical and pathological picture was depicted in the analysis of patients with checkpoint inhibitor-associated myopathy.

4. Cappelli LC, Bingham CO 3rd. Expert perspective: immune checkpoint inhibitors and rheumatologic complications. Arthritis Rheumatol. 2021;73(4):553–65.

5. • Kostine M, Finckh A, Bingham CO, Visser K, Leipe J, Schulze-Koops H, et al. EULAR points to consider for the diagnosis and management of rheumatic immune-related adverse events due to cancer immunotherapy with checkpoint inhibitors. Ann Rheum Dis. 2021;80(1):36–48. https://doi.org/10.1136/annrheumdis-2020-217139. A useful guide on the treatment of irM from a rheumatological approach.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3